AlphaStocks
6.3
Consider Buy

Metlife Inc (MET)

As of Sep 20, 2026, Metlife Inc (MET) scores 6.3/10 on AlphaStocks' five-model composite, #96 of 265 Financials stocks. At $97, MET trades 64% above its model fair value of $59.

Financials / Life & Health Insurance

S&P 500

$97.04

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#96out of 265 in Financials

Is METLIFE INC a Good Investment in 2026?

METLIFE INC (MET) scores 6.3 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates METLIFE INC as Attractive (6/8). The Graham model is the least favorable, rating it Neutral. METLIFE INC currently trades 64% above its estimated fair value of $59. METLIFE INC ranks #96 out of 265 stocks in the Financials sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E19.3ROE11.8Market Cap64BDiv Yield2.4

Estimated Fair Value

$59.0364% above

Trading above estimated fair value. Eps growth of -19% may not justify the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/8

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

67% above fair value

Lynch

Limited Data

High PEG — growth premium

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is METLIFE INC (MET) a good investment?
As of Sep 20, 2026, Metlife Inc (MET) scores 6.3/10 on AlphaStocks' five-model composite, #96 of 265 Financials stocks. At $97, MET trades 64% above its model fair value of $59. That is a middle-of-the-pack score with no strong signal either way.
What is METLIFE INC's Piotroski F-Score?
METLIFE INC's Piotroski F-Score status is Attractive. The raw score is 6/8. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MET overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $59, MET appears overvalued. The stock currently trades 64% above its estimated fair value. Trading above estimated fair value. Eps growth of -19% may not justify the premium.
How does MET compare to other Financials stocks?
METLIFE INC ranks #96 out of 265 stocks in the Financials sector, placing it in the top 36% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about MET?
AlphaStocks evaluates MET using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral. These models are combined into a single composite score of 6.3/10.

Similar Stocks

PRUGLCNO

Compare MET with

MET vs PRUGL vs METCNO vs METMET vs TRV

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer